GSK AND TANABE TO COLLABORATE ON DEVELOPMENT AND COMMERCIALISATI

GSK and Tanabe To Collaborate On Development and Commercialisation Of Preclinical Products Tanabe Seiyaku Co, Ltd. and GlaxoSmithKline plc (GSK) today announce that they have signed a letter of intent to enter into a broad-ranging global collaboration on the research, development and commercialisation of a series of compounds from Tanabe, which covers a range of potential therapeutic areas, including psychiatry, neurology, urology and diabetes. The terms of the Agreement remain to be finalised, but under the letter of intent, GSK will gain access to pre-clinical compounds, with the